Immunic, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate
Immunic, Inc. (IMUX) reported Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate of 0.00% for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Notes › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions and Methodology
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate · last filed 2026-08-11
- Immunic, Inc. share-based compensation arrangement by share-based payment award, fair value assumptions, expected dividend rate for the quarter ending 2026-03-31 was 0.00%.
- Immunic, Inc. share-based compensation arrangement by share-based payment award, fair value assumptions, expected dividend rate for the quarter ending 2025-03-31 was 0.00%.
- Immunic, Inc. share-based compensation arrangement by share-based payment award, fair value assumptions, expected dividend rate for the quarter ending 2024-03-31 was 0.00%.
- Immunic, Inc. share-based compensation arrangement by share-based payment award, fair value assumptions, expected dividend rate for the quarter ending 2023-03-31 was 0.00%.
- Immunic, Inc. share-based compensation arrangement by share-based payment award, fair value assumptions, expected dividend rate for fiscal 2025 was 0.00%.
- Immunic, Inc. share-based compensation arrangement by share-based payment award, fair value assumptions, expected dividend rate for fiscal 2024 was 0.00%.
- Immunic, Inc. share-based compensation arrangement by share-based payment award, fair value assumptions, expected dividend rate for fiscal 2023 was 0.00%.
- Immunic, Inc. share-based compensation arrangement by share-based payment award, fair value assumptions, expected dividend rate for fiscal 2022 was 0.00%.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate 12 month |
|---|---|---|---|---|---|
| 2026-06-30 | 0.00% 10-Q · filed 2026-08-11 | ||||
| 2026-03-31 | 0.00% 10-Q · filed 2026-05-13 | ||||
| 2025-12-31 | 0.00% 10-K · filed 2026-02-26 | ||||
| 2025-09-30 | 0.00% 10-Q · filed 2025-11-13 | ||||
| 2025-06-30 | 0.00% 10-Q · filed 2025-08-07 | ||||
| 2025-03-31 | 0.00% 10-Q · filed 2025-05-15 | ||||
| 2024-12-31 | 0.00% 10-K · filed 2025-03-31 | ||||
| 2024-09-30 | 0.00% 10-Q · filed 2024-11-07 | ||||
| 2024-06-30 | 0.00% 10-Q · filed 2024-08-08 | ||||
| 2024-03-31 | 0.00% 10-Q · filed 2024-05-08 | ||||
| 2024-03-04 | 0.00% 10-K · filed 2026-02-26 | ||||
| 2024-01-08 | 0.00% 10-K · filed 2026-02-26 | ||||
| 2023-12-31 | 0.00% 10-K · filed 2024-02-22 | ||||
| 2023-09-30 | 0.00% 10-Q · filed 2023-11-14 | ||||
| 2023-06-30 | 0.00% 10-Q · filed 2023-08-03 | ||||
| 2023-03-31 | 0.00% 10-Q · filed 2023-05-11 | ||||
| 2022-12-31 | 0.00% 10-K · filed 2023-02-23 | ||||
| 2022-09-30 | 0.00% 10-Q · filed 2022-11-03 | ||||
| 2022-06-30 | 0.00% 10-Q · filed 2022-08-04 | ||||
| 2022-03-31 | 0.00% 10-Q · filed 2022-05-10 | ||||
| 2021-12-31 | 0.00% 10-K · filed 2022-02-24 | ||||
| 2021-09-30 | 0.00% 10-Q · filed 2021-11-04 | ||||
| 2021-06-30 | 0.00% 10-Q · filed 2021-08-06 | ||||
| 2021-03-31 | 0.00% 10-Q · filed 2021-05-06 | ||||
| 2020-09-30 | 0.00% 10-Q · filed 2020-11-06 | ||||
| 2019-03-31 | 0.00% 10-Q · filed 2019-04-10 | ||||
| 2018-12-31 | 0.00% 10-K · filed 2019-03-04 | ||||
| 2018-09-30 | 0.00% 10-Q · filed 2018-11-08 | ||||
| 2017-12-31 | 0.00% 10-K · filed 2019-03-04 | ||||
| 2016-12-31 | 0.00% 10-K · filed 2019-03-04 | ||||
| 2014-03-31 | 0.00% 10-Q · filed 2014-05-28 | ||||
| 2013-03-31 | 0.00% 10-Q · filed 2014-05-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| INOVIO PHARMACEUTICALS, INC. (INO) | United States | $0.125B | -1.35 |
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| Aardvark Therapeutics, Inc. (AARD) | United States | $0.121B | -1.80 |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | United States | $0.121B | -8.95 |
| Coya Therapeutics, Inc. (COYA) | United States | $0.121B | -6.35 |
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| TuHURA Biosciences, Inc./NV (HURA) | United States | $0.134B | -4.88 |
| OnKure Therapeutics, Inc. (OKUR) | United States | $0.119B | -3.13 |
| Curanex Pharmaceuticals Inc (CURX) | United States | $0.138B |